By Django Gold ( August 6, 2012, 5:29 PM EDT) -- A circuit split on the legality of so-called pay-for-delay pharmaceutical patent settlements requires the U.S. Supreme Court to tackle the issue before a trial court reconsiders an antitrust suit against Merck & Co. and another drugmaker, the companies told the Third Circuit on Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.